Cite
National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers.
MLA
Sturgeon, Catharine M., et al. “National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Testicular, Prostate, Colorectal, Breast, and Ovarian Cancers.” Clinical Chemistry, vol. 54, no. 12, Dec. 2008, pp. e11–79. EBSCOhost, https://doi.org/10.1373/clinchem.2008.105601.
APA
Sturgeon, C. M., Duffy, M. J., Stenman, U.-H., Lilja, H., Brünner, N., Chan, D. W., Babaian, R., Bast, R. C., Jr, Dowell, B., Esteva, F. J., Haglund, C., Harbeck, N., Hayes, D. F., Holten-Andersen, M., Klee, G. G., Lamerz, R., Looijenga, L. H., Molina, R., Nielsen, H. J., … Diamandis, E. P. (2008). National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers. Clinical Chemistry, 54(12), e11–e79. https://doi.org/10.1373/clinchem.2008.105601
Chicago
Sturgeon, Catharine M, Michael J Duffy, Ulf-Håkan Stenman, Hans Lilja, Nils Brünner, Daniel W Chan, Richard Babaian, et al. 2008. “National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Testicular, Prostate, Colorectal, Breast, and Ovarian Cancers.” Clinical Chemistry 54 (12): e11–79. doi:10.1373/clinchem.2008.105601.